Prolonged Response with Enzalutamide in a Prostate Cancer Patient on Hemodialysis
Current therapies in oncology that offer a longer and better quality of life are leading to more cases where cancer and chronic diseases coexist. Enzalutamide, a second-generation anti-androgen agent, was approved by the US Food and Drug Administration (FDA) in 2012 for the treatment of metastatic c...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Rabia Yılmaz
2022-11-01
|
| Series: | Journal of Contemporary Medicine |
| Assuntos: | |
| Acceso en liña: | https://dergipark.org.tr/tr/download/article-file/2653132 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|